To include your compound in the COVID-19 Resource Center, submit it here.

FDA announces new user fee rates

FDA released its FY2018 user fee rates for pharmaceuticals and biosimilars Thursday in accordance

Read the full 146 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE